<DOC>
	<DOCNO>NCT01266252</DOCNO>
	<brief_summary>Clinical experience dexmedetomidine paediatric population limit . Critical illness affect drug pharmacokinetics -dynamics ; investigator simply extrapolate adult data use child investigator need data pharmacokinetics pharmacodynamics every paediatric subpopulation .</brief_summary>
	<brief_title>Dexmedetomidine Mechanically Ventilated Neonates With Single-Organ Respiratory Failure .</brief_title>
	<detailed_description>Currently , dexmedetomidine approve United States Food Drug Administration ( FDA ) short-term analgosedation ( &lt; 24h ) mechanically-ventilated critical care adult patient sedation non-intubated adult patient prior and/or surgical procedure . Trials underway investigate pharmacokinetics , clinical efficacy safety long-term use . Clinical experience dexmedetomidine paediatric population limit . Moreover , childhood many developmental change take place consequence drug exposure drug response . Finally , critical illness affect drug pharmacokinetics -dynamics . Therefore , investigator simply extrapolate adult data use child investigator need data pharmacokinetics pharmacodynamics every paediatric subpopulation .</detailed_description>
	<mesh_term>Respiratory Insufficiency</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>patient age le 1 month ( Male/Female ) ( stepdown strategy age ) first include patient ( n=30 ) : postmenstrual age &gt; = 34 week ( nearterm neonate ) follow included patient ( n=30 ) : postmenstrual age &gt; = 25 week &lt; 34 week ( preterm neonate ) patient singleorgan respiratory failure need analgosedation ( guidance : Comfort neo score &gt; 14 Numeric Rating Scale ( NRS ) score Pain ( P ) /Comfort ( C ) &gt; 4 ) patient admit neonatal intensive care unit expect require least 20 hour mechanical ventilation patient neurologic condition prohibit evaluation adequate analgosedation arterial catheter place inclusion patient receive another investigational drug within 30 day patient continuous infusion neuromuscular blocker patient life expectancy &lt; 72 hour patient know allergy fentanyl congenital acquire heart block ( grade 3 ) sustain bradycardia haemodynamically unstable patient ( definition : Mean Arterial Pressure ( MAP ) low : postmenstrual age ( week ) 5 millimeter Hg , eventually dopamine infusion max . 16 mcg/kilogram/minute and/or dobutamine infusion maximal 16 mcg/kilogram/minute ) patient significant renal insufficiency ( creatinine plasma level &gt; 1.5 milligram/deciliter ) patient significant hepatic insufficiency ( estimate local investigator ) previous treatment Î±2adrenoreceptor agonist clonidine within 14 day absence parental consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>neonate</keyword>
	<keyword>single organ respiratory failure</keyword>
</DOC>